Abstract
Systemic sclerosis (SSc) is an autoimmune disease characterized by skin and internal organs fibrosis due to an extracellular matrix (ECM) accumulation of type I collagen. The turnover of the ECM is dependent on the balance between matrix metalloproteinases (MMPs) and tissue inhibitors of matrix metalloproteinases (TIMPs). The disruption of this balance is involved in SSc because higher serum TIMP‐1 levels have been demonstrated in SSc patients than in controls. On this basis, we analyzed three polymorphisms: −19A>G, +261C>T, and +372T>C of the TIMP‐1 gene in SSc patients (67 females, eight males) and controls (29 females, nine males). The C allele of the +372T>C single nucleotide polymorphism (SNP) was observed at a higher frequency in male patients than in healthy individuals (P=0.02), while no differences were observed in the female subjects. Our findings suggest that the +372T>C polymorphism of the TIMP‐1 gene is associated with SSc in male individuals. No association with the clinical characteristics of SSc Italian patients and TIMP‐1 gene polymorphisms was observed. Thus, the role of TIMP‐1 gene in predisposition to SSc remains controversial. J. Clin. Lab. Anal. 20:173–176, 2006. © 2006 Wiley‐Liss, Inc.
Keywords: systemic sclerosis, tissue inhibitor of matrix metalloproteinases, single nucleotide polymorphism, clinical characteristics
REFERENCES
- 1. Chen K, See A, Shumack S. Epidemiology and pathogenesis of scleroderma. Australas J Dermatol 2003;44:1–7. [DOI] [PubMed] [Google Scholar]
- 2. Sato S, Fujimoto M, Hasegawa M, Takehara K. Altered blood B lymphocyte homeostasis in systemic sclerosis: expanded naive B cells and diminished but activated memory B cells. Arthritis Rheum 2004;50:1918–1927. [DOI] [PubMed] [Google Scholar]
- 3. Hamamdzic D, Kasman LM, LeRoy EC. The role of infectious agents in the pathogenesis of systemic sclerosis. Curr Opin Rheumatol 2002;14:694–698. [DOI] [PubMed] [Google Scholar]
- 4. Johnson RW, Tew MB, Arnett FC. The genetics of systemic sclerosis. Curr Rheumatol Rep 2002;4:99–107. [DOI] [PubMed] [Google Scholar]
- 5. Uitto J, Bauer EA, Eisen AZ. Scleroderma. Increased biosynthesis of triple helical type I and type III procollagens associated with unaltered expression of collagenase by skin fibroblasts in culture. J Clin Invest 1979;64:921–930. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Young‐Min SA, Beeton C, Laughton R, et al. Serum TIMP‐1, TIMP‐2, and MMP‐1 in patients with systemic sclerosis, primary Raynaud's phenomenon, and in normal controls. Ann Rheum Dis 2001;60:846–851. [PMC free article] [PubMed] [Google Scholar]
- 7. Kikuchi K, Kadono T, Furue M, Tamaki K. Tissue inhibitor of metalloproteinase 1 (TIMP‐1) may be an autocrine growth factor in scleroderma fibroblasts. J Invest Dermatol 1997;108:281–284. [DOI] [PubMed] [Google Scholar]
- 8. Krex D, Rohl H, Konig IR, Ziegler A, Schackert HK, Schackert G. Tissue inhibitor of metalloproteinases‐1, ‐2, and ‐3 polymorphisms in a white population with intracranial aneurysms. Stroke 2003;34:2817–2821. [DOI] [PubMed] [Google Scholar]
- 9. Johnson RW, Reveille JD, McNearney T, et al. Lack of association of a functionally relevant single nucleotide polymorphism of matrix metalloproteinases‐1 promoter with systemic sclerosis (scleroderma). Genes Immunol 2001;2:273–275. [DOI] [PubMed] [Google Scholar]
- 10. Bou‐Gharios G, Osman J, Black C, Olsen I. Excessive matrix accumulation in scleroderma is caused partly by differential regulation of stromelysin and TIMP‐1 synthesis. Clin Chim Acta 1994;231:69–78. [DOI] [PubMed] [Google Scholar]
- 11. Marisini B, Casari S, Zeni S, Turri O, Biondi ML. Stromelysin promoter polymorphism is associated with systemic sclerosis. Rheumatology 2001;40:475–476. [DOI] [PubMed] [Google Scholar]
- 12. Kuroda K, Shinkai H. Gene expression of Types I and II collagen, decorin, matrix metalloproteinases and tissue inhibitors of metalloproteinases in skin fibroblasts from patients with systemic sclerosis. Arch Dermatol Res 1997;289:567–572. [DOI] [PubMed] [Google Scholar]
- 13. Susol E, Rands AL, Herrick A, et al. Association of markers for TGFbeta3, TGFbeta2 and TIMP1 with systemic sclerosis. Rheumatology 2000;39:1332–1336. [DOI] [PubMed] [Google Scholar]
- 14. Aicher WK, Alexander D, Haas C, et al. Transcription factor early growth response 1 activity up‐regulates expression of tissue inhibitor of metalloproteinases 1 in human synovial fibroblasts. Arthritis Rheum 2003;48:348–359. [DOI] [PubMed] [Google Scholar]
- 15. Dean G, Young DA, Edwards DR, Clark IM. The human tissue inhibitor of metalloproteinases (TIMP)‐1 gene contains repressive elements within the promoter and intron 1. J Biol Chem 2000;275:32664–32671. [DOI] [PubMed] [Google Scholar]